Read the biology.
Investigate disease-associated patterns across broad microRNA profiles.
miRoncol is building a microRNA intelligence company around an ambitious preventive-health idea: recognize meaningful biological change earlier, understand it in personal context and help protect more years of healthy life.


Most healthcare begins after a symptom, an abnormal test or a visible change. miRoncol is building for the earlier window, when biological information may create time for further investigation and more informed action.
Make earlier prevention against the diseases that shorten healthspan accessible to everyone.
Build microRNA intelligence for preventive health using convenient biological samples, AI-assisted pattern recognition and longitudinal data.
Translate the first peer-reviewed publication of a miRNA-based multi-cancer early detection model into the miCheckup Early Cancer Detection Test.
The opportunity is not created by one technology alone. It requires discovery, clinical discipline, computational intelligence and thoughtful translation working together.
Investigate disease-associated patterns across broad microRNA profiles.
Connect AI-assisted pattern recognition with meaningful clinical questions and physician-led care.
Move validated signals into focused tests that can be delivered consistently in real clinical settings.
Prevention first. Evidence before assertion. Clinical care remains central. Every application must earn its place through research, validation and responsible use.
Meet the people responsible for that work